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In this study, polyphenols (LSP) were obtained from the fermentation broth of Lachnum
singerianum. Two fractions were isolated by Sephadex LH-20 chromatographic column, and
the primary fraction (LSP-1) was collected. The comprehensive physicochemical properties
of phenolic acids and polyhydroxy phenolic compounds of LSP-1 were determined by UV-
visible spectroscopy, Fourier transform infrared spectroscopy, and gas chromatography
emass spectrometry. Results of anticoagulant activity assay in vitro showed that LSP-1
could lengthen prothrombin time, activated partial thromboplastin time, and thrombin
time of mouse plasma. In addition, anticoagulant activity results in vivo showed that high
dose of LSP-1 could significantly prolong bleeding time, coagulation time, prothrombin
time, activated partial thromboplastin time, and thrombin time of hypercoagulable mice
induced by adrenaline, reduce the content of fibrinogen and enhance antithrombin III
activity. All results indicated that the LSP-1 could serve well as an anticoagulant, and might
be used as a potential natural drug candidate for thrombosis.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prevention and treatment of thrombotic diseases has become
one of the demanding tasks in medicine as thrombosis be-
comes themain cause of acutemyocardial infarction, cerebral
infarction, and other cardiovascular diseases [1].
Formation of thrombus is mainly attributed to the damage
of the cardiovascular wall, changes of blood state, and phys-
icochemical properties [2,3]. Generally, the coagulation andnce and Engineering, Hef
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rug Analysis (2016), http:/anticoagulation systems are maintained in dynamic equilib-
rium in organisms. Inhibition of blood coagulation can be used
as an important means to prevent formation of thrombosis
[4,5]. Coagulation process is complex in the human body, and
the key step for coagulation formation is to transform fibrin-
ogen into fibrin, which is catalyzed by thrombin [6].
Polyphenols are widely distributed in fruits, vegetables,
nuts, seeds, flowers, and saprophytic fungi [7,8]. Epidemio-
logical studies have indicated that polyphenols could prevent
the occurrence of cardiovascular diseases and maintain theei University of Technology, Hefei 230009, China.
hed by Elsevier Taiwan LLC. This is an open access article under the CC
operties and anticoagulant activity of polyphenols derived from
/dx.doi.org/10.1016/j.jfda.2016.08.011
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e82integrality of blood vessels [9e12]. Curcumin, one of the
polyphenolic compounds, can significantly prolong activated
partial thromboplastin time (APTT) and prothrombin time
(PT), and suppress activity of thrombin and the production of
factor Xa. Therefore, curcumin can inhibit blood coagulation
and formation of thrombus by endogenous and exogenous
pathway [5]. Flavonoids in purple grape juice could inhibit
platelet aggregation, increase endogenous platelet-derived
nitric oxide, thus reducing endogenous peroxides [13]. Poly-
phenols of grape seed and Aronia melanocarpa can prolong the
blood coagulation time [APTT, PT, thrombin time (TT)] and
reduce the maximal velocity of fibrous protein aggregation
[14].
Lachnum is a genus of saprophytic fungi in the family
Hyaloscyphaceae which is distributed throughout the world
[15]. So far, more than 250 species of Lachnum have been re-
ported [16] and some can produce a variety of active metab-
olites such as polysaccharide [17], pigment [18], and lipid [19].
Previous studies have also found that Lachnum could produce
polyphenols, which have antioxidation, antibacterial, and
other biological activities and play an important role in food
quality [20,21]. The aims of the study were to evaluate the
physicochemical properties, anticoagulant effect and explore
the mechanism of polyphenols.2. Materials and methods
2.1. Materials
The fruiting bodies of Lachnum singerianum YM296 were
collected from Huangshan, Anhui, China and then separated
and preserved in the Microbial Resource and Application
Laboratory of Hefei University of Technology.
Fibrinogen (FIB) kit, PT kit, TT kit, antithrombin III (ATIII)
kit, and APTT kit were purchased from Nanjing Jiancheng
Technology Co., Ltd (Nanjing, China). Aspirin enteric-coated
tablets was purchased from Shenyang Aojina Pharmaceu-
tical Co., Ltd (Shenyang, China). Sephadex LH-20 was pur-
chased from Sigma Chemical Co., iMark ELIAS (Bio-Rad,
Hercules, CA, USA).
2.2. Experimental animals
Forty male Kunming mice, weight 25 ± 1 g, were provided by
the Experimental Animal Center of Anhui Medical University
(Certificate number: No. 1 license of the Medical Laboratory
Animal of Anhui). The mice were kept at 23 ± 2C with hu-
midity of 55 ± 5%, and cultured in a 12 h:12 h lightedark cycle.
All procedures involving animals were conducted in accor-
dance with the guidelines of Regulations for the Administra-
tion of Affairs Concerning Experimental Animals of
Institutional Animal Care and Use Committee (IACUC).
2.3. Extraction and purification of L. singerianum
polyphenols
L. singerianum was incubated at 26C, 160 rpm for 8 days. The
composition of cultivated broth is 20 g/L sucrose, 5 g/L
peptone, 0.8 g/L MgCl2, 0.01 g/L tyrosine, and natural pH. AfterPlease cite this article in press as: Zong S, et al., Physicochemical pr
Lachnum singerianum, Journal of Food and Drug Analysis (2016), http:the completion of fermentation, the broth was concentrated
by vacuum rotary evaporation. Three times the volume of 70%
ethanol was added, and the solution was placed at 4C for
24 hours. The supernatant was collected and evaporated to
eliminate ethanol. The solution was extracted with iso-
volumetric ethyl acetate and evaporated to remove organic
phase. The crude polyphenols were lyophilized at 40C for
24 h and isolated by Sephadex LH-20 chromatographic col-
umn. The loading concentration of the sample was 20 mg/mL.
The eluent was methanol at a flow rate of 1 mL/min and was
detected at 280 nm by spectrophotometer. The main fraction
was gathered, concentrated, and lyophilized to obtain L.
singerianum polyphenol (LSP)-1 [22].
2.4. Physicochemical characterization of LSP -1
2.4.1. UV and Fourier transform infrared spectroscopy
characterization
LSP-1 was dissolved in methanol and recorded by a UV spec-
trophotometer with scanning range of 200e800 nm.
The IR absorption of LSP-1 was measured with KBr pellet
(mass ratio 1:100) by Fourier transform infrared spectroscopy
(FT-IR) spectrometer Nicolet 67 with the scanning range of
400e4000/cm.
2.4.2. Gas chromatographyemass spectrometry analysis
The method of Masek et al [23] was used with minor amend-
ments: 50mg LSP-1 was dissolved in 2mLmethanol tomake a
clear solution. After being dried with N2, 100 mL N,O-bis(-
trimethylsilyl)trifluoroacetamide and 50 mL pyridine were
added to the solution. Then the mixture was oscillated for
0.5 min and derived in the oven at 70C for 45 min. Spectro-
gram was analyzed by the NIST 11 MS Database and MS
Search Program 2.0.
Gas chromatographyemass spectrometry (GC-MS) anal-
ysis conditions are as follows: Quartz capillary column HP-5
(30 m  0.25 mm  0.25 mm), 1 mL of the derived solution was
injected into injection port. Temperature programming was
selected for column temperature which was increased from
50C to 250C at rate of 10C/min. Temperature of the injection
port was 280C, while flow rate of He was 1 mL/min. The ion
source was electrospray ionization and the electron bombing
energy is 70 eV.
2.5. Anticoagulant activity assay in vitro
The mice were hocused with pentobarbital sodium solution
before the eyeballs of mice were picked out to obtain the
sample blood which had been exposed to the drug for 10 mi-
nutes. The sample blood was put into the centrifuge tube
which contained 3.8% sodium citrate (whole blood:
anticoagulant ¼ 9:1, v/v), and was gently blended uniformly.
After being centrifuged at 960 g for 10 minutes, the superna-
tant of the sample blood was collected and tested within
2 hours. Aliquots of 50 mL of plasmawere added into 25 mL LSP-
1 solutions with concentrations of 50 mg/L, 100 mg/L, 150 mg/
L, and 200 mg/L. To the negative and positive control groups,
other than plasma, the same amount of saline and 50 mg/L
aspirin were added, respectively. APTT, TT, and PT were
determined according to the instructions of the enzyme-operties and anticoagulant activity of polyphenols derived from
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out in parallel three times.
2.6. Anticoagulant activity assay in vivo
After being kept for environmental adaptation for l week, the
mice were randomly and equally divided into six groups,
including normal control group, model control group, positive
control group (20 mg/kg aspirin, mixed with carboxymethyl
cellulose suspension), high-dose group (80 mg/kg LSP-1), me-
dium-dose group (40 mg/kg LSP-1), and low-dose group
(20 mg/kg LSP-1). The high coagulation models were built
successfully by injecting adrenaline hydrochloride into the
same place beneath the mice skin, after which the mice could
be further divided into model group, positive group, high,
medium, and low dose of LSP-1 groups. For the normal control
group, the mice were just continuously injected with equi-
voluminal saline for 14 days [24]. Adrenaline could make the
body in a hypercoagulable state, which was assessed by the
experiment diagnosis index: AT-III  70%. In addition, TT,
APTT or PT, and APTT were shortened significantly [25].
After 15 days, each group was gavaged with corresponding
drug dose once a day. The mice in the normal and model
groups were injected with equivoluminal saline. Then, the
mice were successively administrated for 14 days. Drinking
water was freely available for mice during administration. By
the end of gavage, the mice fasted for 12 hours. Coagulation
time (CT) and bleeding time (BT) were measured 1 hour after
the last administration, and the mice were then hocused and
the blood was collected by removing their eyeballs. Fresh
whole blood was put into a centrifuge tube with sodium cit-
rate as anticoagulant (whole blood: anticoagulant ¼ 9:1, v/v)
and was blended completely. After being centrifuged at 706 g
for 5 minutes, the centrifugal supernatant was collected,
which was used to measure PT, APTT, FIB, TT, and AT-III.
2.6.1. Determination of CT
One hour after the last gavage treatment, the mice were ho-
cused. According to the method [26], coagulation time of
whole blood was set. The tails of mice were sliced to obtain
blood and then a drop of blood was placed on a slide with the
timing starting. A syringe needle was used to stir the blood.
The time of fibrin filament formationwas recorded. Blood that
was not provoked was used as control.
2.6.2. Determination of BT
The method of Cui et al [27] was used with minor amend-
ments. One hour after the last gavage treatment, tails of the
mice were wiped with alcohol to expand blood vessels. Af-
terwards, tails were cut at the point 0.5 cm away from the tip
with scissors, and time was recorded immediately. The blood
was sucked with filter paper every 20 s until the tails stopped
bleeding (the time of no blood on filter paper as the criterion),
and the BT was recorded.
2.6.3. Determination of FIB content
By the effect of excessive thrombin, soluble fibrinogen in
plasma was transformed into insoluble aggregates and then
formed into fibrin clots. Therefore, solidification time of
plasma was inversely proportional to FIB content.Please cite this article in press as: Zong S, et al., Physicochemical pr
Lachnum singerianum, Journal of Food and Drug Analysis (2016), http:/For preparation of standard curve, FIB standards were
dissolved in deionized water to make a stock solution. The
stock solution was diluted with imidazole buffer at the pro-
portion of 1:5 (100 mL FIB: 500 mL imidazole buffer), 1:10, 1:15,
1:20, and 1:30 to make different concentrations. A 100-mL
sample of thrombin was added into 200 mL FIB working solu-
tions with different concentrations and the mixtures were
pretreated at 37C for 3 minutes. The solidification time was
then recorded. A standard curve was drawn on logelog paper
with different concentration of fibrinogen standard (mg/dL) as
the abscissa and coagulation time as the ordinate.
Testing plasma was diluted with the imidazole buffer at
1:10 (100 mL plasma: 1000 mL imidazole buffer) to make a so-
lutionwhichwas pretreated at 37C for 3minutes. After 100 mL
thrombin was added into 200 mL solution, the solidification
time was measured. The content of FIB was determined ac-
cording to the standard curve.
2.6.4. Determination of AT-III activity
Chromogenic assays were used to determine the activity of
AT-III. When concentration of the thrombin in blood was too
high, thrombin could be combined with the AT-III in the
plasma and formed into a complex that had no clotting ac-
tivity. Unreacted thrombin would act on chromogenic peptide
substrate Chromozym P to promote release of paranitroani-
line, which has strong absorption at 405 nm. Thus, adsorption
intensity of paranitroaniline in 405nm was inversely propor-
tional to the activity of AT-III.2.7. Statistical analysis
All data were processed by SPSS 18.0 statistical software and
represented as mean ± standard deviation. The t test analysis
and one-way analysis of variance were used to analyze the
differences between groups with p < 0.05 indicating a signifi-
cant difference and p < 0.01 a very significant difference.3. Results and discussion
3.1. Isolation and purification of polyphenols from L.
singerianum
Polyphenols were isolated from L. singerianum extracted by
Sephadex LH-20 chromatographic column, and the primary
fraction (LSP-1) was collected (Figure 1A).3.2. Physicochemical characterization of LSP -1
3.2.1. UV-visible characterization
As shown in Figure 1B, there were two obvious ultraviolet
absorption peaks at 222 nm and 269 nm (II belt) in the range of
200e300 nm. Theywere typical ultraviolet absorption peaks of
phenolic components with benzoyl structure [23,28]. In addi-
tion, there was no ultraviolet absorption in the range of
300e400 nm which represented the characteristic absorption
peaks of the flavonoids (I belt). Therefore, the primary content
of extract was not flavonoids [29] but polyphenols.operties and anticoagulant activity of polyphenols derived from
/dx.doi.org/10.1016/j.jfda.2016.08.011
Figure 1 e (A) Chromatogram of Lachnum singerianum
polyphenols on Sephadex LH-20 column and (B) UV-visible
spectrum of Lachnum singerianum polyphenols.
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Figure 2 e Fourier transform infrared spectroscopy of
Lachnum singerianum polyphenol-1.
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Figure 3 e Total ion chromatogram of Lachnum singerianum
polyphenols.
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In the FT-IR spectrum (Figure 2), a broad peak at 3350/cm was
assigned to the stretching vibration of eOH [30], while an
adsorption peak at 2948/cm was caused by stretching vibra-
tion of ¼ CeH in the benzene ring [31]. The peak at 1700/cm
was resulted from stretching vibration of C]O [30]. Two ab-
sorptions at 1560/cm and 1430/cm suggested that LSP-1 con-
tained stretching vibration of aromatic ring [32], while the
peak at 1200/cm was caused by the bending vibration of
phenolic hydroxyl group. These results indicate that LSP-1
was composed of phenolic acids or polyhydric phenolics.
3.2.3. GC-MS analysis
Phenolic compounds of LSP-1 were identified by GC-MS [23].
Seven kinds of phenolic compounds and their corresponding
structures were determined by the NIST 11 MS Database and
MS Search Program 2.0 (Figure 3 and Table 1). The total ion
chromatogram of LSP-1 in Figure 3 indicated that the mainPlease cite this article in press as: Zong S, et al., Physicochemical pr
Lachnum singerianum, Journal of Food and Drug Analysis (2016), http:ingredients of LSP-1 were phenolic acids, including 2,5-
dihydroxybenzoic acid (Compound 4), 4-methylsalicylic acid
(Compound 6), and 4-hydroxyphenyl lactic acid, ethyl ester
(Compound 7). The other ingredients were polyhydric phe-
nolics. The results of UV-vis and FT-IR also indicated that
compounds of LSP-1 were phenolic acid derivatives with
benzoyl structure.
3.3. Anticoagulant activity assay in vitro
Coagulant and anticoagulant system in the body were in a
dynamic equilibrium. Disorder of the body balance could
cause the myocardial infarction, thrombosis, and other blood
coagulation with thrombus being a common disease among
the old. The activation of the anticoagulation system is an
important mechanism for antithrombosis.
Resulting from a series of enzymatic reactions, coagulation
process in the body could be divided into three stages: formingoperties and anticoagulant activity of polyphenols derived from
//dx.doi.org/10.1016/j.jfda.2016.08.011
Table 1 e GC-MS analysis data of Lachnum singerianum polyphenol-1.
Retention time (min) Name Structure
1 17.18 Hydroquinone
2 18.31 5-tert-Butylpyrogallol
3 20.09 3,5-Dimethoxycinnamic acid
4 21.62 2,5-Dihydroxybenzoic acid
5 23.51 3-Methyl-hydroxybenzoic benzoic acid
6 26.57 4-Methylsalicylic acid
7 28.12 4-Hydroxyphenylactic acid, ethyl ester
Table 2 e Effect of Lachnum singerianum polyphenol-1
(LSP-1) on activated partial thromboplastin time (APTT),
prothrombin time (PT), and thrombin time (TT).
Group Dose (mg/L) APTT (s) PT (s) TT(s)
Control 25.67 ± 2.75 14.60 ± 1.05 19.4 ± 0.95
LSP 50 32.57 ± 2.93a 17.37 ± 0.85 26.7 ± 1.25b
100 54.93 ± 1.88b 23.27 ± 1.60b 30.43 ± 1.86b
150 67.57 ± 3.89b 27.50 ± 2.10b 37.07 ± 1.90b
200 87.03 ± 2.53b 32.17 ± 2.48b 58.83 ± 2.25b
Asp 50 119.23 ± 3.55b 39.73 ± 2.60b 85.20 ± 2.72b
a p < 0.05, b p < 0.01, compared with the control group.
j o u rn a l o f f o o d and d r u g a n a l y s i s x x x ( 2 0 1 6 ) 1e8 5of thrombin activator; activation of prothrombin to thrombin;
and transforming of fibrinogen into fibrin [33]. Initiated by
different procedures, the coagulation process could be divided
into exogenous and endogenous coagulation pathway. APTT
extension reaction was caused by intrinsic coagulation and
common coagulation pathways. PT extension reaction repre-
sented the exogenous coagulation pathway [34,35]. The TT
extension reaction reflected both exogenous and endogenous
coagulation pathways.
LSP-1 (100 mg/mL, 150 mg/mL, 200 mg/mL) could prolong
APTT, PT, and TT significantly (p < 0.01). In addition, with the
increased dose, APTT, PT, and TTwere lengthened, exhibiting a
dose-effect relationship (Table 2),whichwas similar toprevious
results [5]. The results showed that LSP-1 had inhibition effects
on both endogenous and exogenous coagulation systems.
3.4. Anticoagulant activity assay in vivo
3.4.1. Determination of CT and BT
Adrenaline could facilitate the peripheral vascular to contract
and increase the load on the heart. In addition, it increases the
consumption of myocardial oxygen and decreases the cardiac
function, causing blood circulation disorders. The mice were
injected into adrenaline repeatedly which could simulate
longer depression, causing higher viscosity and convert
mouse blood to a hypercoagulable state [24]. CT and BT are
basic indices to evaluate anticoagulation in vivo. BT related toPlease cite this article in press as: Zong S, et al., Physicochemical pr
Lachnum singerianum, Journal of Food and Drug Analysis (2016), http:/the number and the function of platelet, the function of tissue
factor, the function of the capillary, etc. CT can reflect the
anticoagulation factor activity and the coagulation factor
function [36].
Compared with the normal group, CT and BT in the model
groupwere reduced significantly (p < 0.01). Comparedwith the
model group, CT and BT in the dose group and aspirin group
were extended differently.With the increasing of dose, CT and
BT also increased, showing a dose-effect relationship to a
certain extent. CT and BT were significantly prolonged in
middle- and high-dose groups (p < 0.01). CT and BT in normal
group and high-dose group had no significant differences
(Figure 4).operties and anticoagulant activity of polyphenols derived from
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As shown in the Figure 5, compared with normal group, PT,
APTT and TT in model group were decreased significantly
(p < 0.01). The result showed that adrenaline could convert the
blood ofmice to a hypercoagulable state. Therefore, themodel
was established successfully. PT, APTT, and TT in the poly-
phenol dose groups were prolonged. The results between
middle- and high-dose groups were compared and the effects
of LSP-1 on PT, APTT, and TT were significant (p < 0.01).
Overall, the results in vivo and in vitro indicated that LSP-1 had
a synergic anticoagulant effect by endogenous and exogenous
pathway [37].
3.4.3. Determination of FIB content
FIB is one of the highest concentration coagulation proteins in
plasma. By the action of thrombin, FIB can form insoluble
fibrin, which played an important role in the agglutination
process of platelets [38]. Increasing fibrinogen levels canA B C D E F
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Figure 4 e Effects of Lachnum singerianum polyphenol-1 on
(A) coagulation time and (B) bleeding time of the model
mice. A ¼ normal control group; B ¼ model control group;
C ¼ low-dose group; D ¼ middle-dose group; E ¼ high-
dose group; F ¼ positive control group.
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Figure 5 e Effects of Lachnum singerianum polyphenol-1 on
(A) activated partial thromboplastin time, (B) prothrombin
time, and (C) thrombin time of the model mice. A¼ normal
control group; B ¼ model control group; C ¼ low-dose
group; D ¼ middle-dose group; E ¼ high-dose group;
F ¼ positive control group.
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Figure 7 e Effect of Lachnum singerianum polyphenol-1 on
the antithrombin-III activity of themodel mice. A¼ normal
control group; B ¼ model control group; C ¼ low-dose
group; D ¼ middle-dose group; E ¼ high-dose group;
F ¼ positive control group.
j o u rn a l o f f o o d and d r u g a n a l y s i s x x x ( 2 0 1 6 ) 1e8 7increase blood viscosity and retard blood flow, and is an in-
dependent risk factor for blood in a hypercoagulable state [39].
As can be seen from Figure 6, the fibrinogen content of the
model group was significantly higher than that of the normal
group (p < 0.01). Higher fibrin content could be found in me-
dium- and high-dose groups. The dose groups had significant
differences compared the model group. The result suggests
that Lachnum polyphenols might accelerate the cleavage of
FIB, inhibit the aggregation of platelet, and adjust the rheology
of blood by activating the fibrinolytic system.
3.4.4. Determination of AT-III activity
AT-III, synthesized by liver cells, macrophages, and endothe-
lial cells, is a single-chain glycoprotein and a multifunctional
serine protease inhibitor, playing an important role in the
anticoagulation system. It can form a complex with heparin,
which could accelerate inactivation of thrombin and thus
inhibit the coagulation of blood [6].
As shown in Figure 7, compared with the normal control
group, the AT-III activity of the model group was significantly
decreased. The underlying reason might be that adrenaline
activated the coagulation factors in mice, which caused to
produce large amounts of thrombin, and thus a lot of AT-III
was consumed. Compared with the model group, AT-III ac-
tivity of the positive control group was increased, but
compared with the model group, there were no significant
differences. The activity of AT-III in the high dose group was
significantly enhanced. Possible reasons include that LSP-1
could significantly reduce the content of FIB, leading to
decrease of the binding of fibrinogen and thrombin. In addi-
tion, after LSP-1 is absorbed into the blood stream, carboxyl of
LSP-1 might reaction with metal ions to form a pendant group
containing a carboxylate that could increase the anticoagu-
lant III activity by modifying the affinity of AT-III proteins [40].
The exact mechanism underlying the enhancement of AT-III
activity by LSP-1 needs further research.A B C D E F
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Figure 6 e Effect of Lachnum singerianum polyphenol-1 on
fibrinogen of the model mice. A ¼ normal control group;
B ¼model control group; C ¼ low-dose group; D ¼middle-
dose group; E ¼ high-dose group; F ¼ positive control
group.
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In this study, we evaluated the physicochemical properties and
anticoagulant activity of the primary fraction (LSP-1) of poly-
phenols obtained from the fermentation broth of L. singerianum
for the first time. Phenolic acids and polyhydroxy phenolic
compounds of LSP-1 were determined. The results showed that
LSP-1 had an inhibition effect on endogenous and exogenous
coagulationsystem invitro. In-vitro tests indicated thatLSP-1had
significant anticoagulant activity compared to normal group.
The mechanism of anticoagulation might be related to the
improvement of AT-III activity induced by LSP-1. All these pos-
itive results suggest that LSP-1 is very promising for the future
developmentofananticoagulantdrugcandidateforthrombosis.Conflicts of interest
The authors declare no competing financial interest.
Acknowledgments
This work was financially supported by the National Natural
Science Foundation of China (No. 31270060).r e f e r e n c e s
[1] Mathers CD, Loncar D. Projections of global mortality and
burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
[2] Anand M, Rajagopal K, Rajagopal KR. A model for the
formation and lysis of blood clots. Pathophysiol Haemostat
Thromb 2005;34:109e20.operties and anticoagulant activity of polyphenols derived from
/dx.doi.org/10.1016/j.jfda.2016.08.011
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e88[3] Biggs R, Douglas AS, Macfarlane RG. The formation of
thromboplastin in human blood. J Physiol 1953;119:89e101.
[4] Davie EW. Biochemical and molecular aspects of the
coagulation cascade. Thromb Haemost 1995;74:1e6.
[5] Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin
and its derivative. Biochem Mol Biol Rep 2012;45:221e6.
[6] Dahlb€ack B. Blood coagulation. Lancet 2000;355:1627e32.
[7] Bai L, Guo S, Liu Q, Cui X, Zhang X, Zhang L, Yang X, Hou M,
Ho CT, Bai N. Characterization of nine polyphenols in fruits
of Malus pumila mill by high-performance liquid
chromatography. J Food Drug Anal 2016;43:1071e81.
[8] Li W, He N, Tian L, Shi X, Yang X. Inhibitory effects of
polyphenol-enriched extract from Ziyang tea against human
breast cancer MCF-7 cells through reactive oxygen species-
dependent mitochondria molecular mechanism. J Food Drug
Anal 2016;1e12.
[9] Nardini M, Natella F, Scaccini C. Role of dietary polyphenols
in platelet aggregation. A review of the supplementation
studies. Platelets 2007;18:224e43.
[10] Hussein L, Medina A, Barrionnevo A, Lammuela-
Raventos RM, Andres-Lacueva C. Normal distribution of
urinary polyphenol excretion among Egyptian males 7e14
years old and changes following nutritional intervention
with tomato juice (Lycopersicon esculentum). Int J Food Sci Nutr
2008;60:302e11.
[11] Jastrzebski Z, Medina OJ, Moreno LM, Gorinstein S. In vitro
studies of polyphenol compounds, total antioxidant capacity
and other dietary indices in a mixture of plants (Prolipid). Int
J Food Sci Nutr 2007;58:531e41.
[12] Rechner AR, Kroner C. Anthocyanins and colonic metabolites
of dietary polyphenols inhibit platelet function. Thromb Res
2005;116:327e34.
[13] Freedman JE, Parker C, Li L, Perlman JA, Frei B, Ivanov V,
Deak LR, Iafrati MD, Folts JD. Select flavonoids and whole
juice from purple grapes inhibit platelet function and
enhance nitric oxide release. Circulation 2001;103:2792e8.
[14] Bijak M, Bobrowski M, Borowiecka M, Podse˛dek A, Golanski J,
Nowak P. Anticoagulant effect of polyphenols-rich extracts
from black chokeberry and grape seeds. Fitoterapia
2011;82:811e7.
[15] Ye M, Chen X, Li GW, Guo GY, Yang L. Structural
characteristics of pheomelanin-like pigment from Lachnum
singerianum. Adv Mater Res 2011;284e286:1742e5.
[16] Ye M, Chen WX, Qiu T, Yuan RY, Ye YW, Cai JM. Structural
characterisation and anti-ageing activity of extracellular
polysaccharide from a strain of Lachnum sp. Food Chem
2012;132:338e43.
[17] He Y, Ming Y, Jing L, Du Z, Surahio M, Xu H, Li J. Preparation,
characterization and bioactivities of derivatives of an
exopolysaccharide from Lachnum. Carbohyd Polym
2015;117:788e96.
[18] Ye M, Guo GY, Lu Y, Song S, Wang HY, Yang L. Purification,
structure and anti-radiation activity of melanin from
Lachnum YM404. Int J Biol Macromol 2013;63:170e6.
[19] Lu Y, Ni L, Qian MS, Ye M. Purification of methyl linoleate
and analysis of oils produced by Lachnum mutant strain.
Food Sci Tech 2013;38:15e20.
[20] Qian MS, Ji J, Ye M, Shaikh F, Wang HY, Yang L. Effect of nitric
oxide on Lachnum YMU50 extracellular polyphenol
accumulation and antioxidant defense system. Appl
Biochem Biotech 2014;174:1761e70.
[21] Qian MS, Ji J, Chen TL, Yang L, Ye M. Physicochemical
characteristics and biological activities of polyphenols from
Lachnum. Adv Microbiol 2013;2:102e8.
[22] Pfundstein B, Desouky SKE, Hull WE, Haubner R, Erben G,
Owen RW. Polyphenolic compounds in the fruits of Egyptian
medicinal plants (Terminalia bellerica, Terminalia chebula andPlease cite this article in press as: Zong S, et al., Physicochemical pr
Lachnum singerianum, Journal of Food and Drug Analysis (2016), http:Terminalia horrida): characterization, quantitation and
determination of antioxidant capacities. Phytochemistry
2010;71:1132e48.
[23] Masek A, Chrzescijanska E, Kosmalska A, Zaborski M.
Characteristics of compounds in hops using cyclic
voltammetry, UVeVIS, FTIR and GCeMS analysis. Food
Chem 2014;156:353e61.
[24] Lan HE, Jiang WY, Mao TM. Preliminary exploration on
establishing a simulated model of acute and chronic after-qi-
stagnation blood stasis by adrenaline injection. Zhongguo
Zhong Xi Yi Jie He Za Zhi 2004;24:244e6.
[25] Wang GZ, Li XL, Ma SL. Study on the treatment of allergic
purpura with high coagulation state and heparin
anticoagulant therapy. Appl J Gen Pract 2007;5:901e2.
[26] Guo Q, Lianda LI, Hao W, Zhao L, Xianghuib QI. Effects of
recombination of effective constituent of cortex moutan on
platelet aggregation and blood coagulation in rabbits. Chin J
Mod Appl Pharm 2010;27:967e70.
[27] Cui Y, Zhang J, Zhang R, Huang L. Study on structure analysis
and anticoagulant function in vitro of Garlic polysaccharides.
Food Fermen Ind 2009;35:24e7.
[28] Markham KR. Flavones, flavonols and their glycosides. Meth
Plant Biochem 1989;1:197e235.
[29] He JB, Wang Y, Deng N, Lin XQ. Study of the adsorption and
oxidation of antioxidant rutin by cyclic
voltammetryevoltabsorptometry. Bioelectrochemistry
2007;71:157e63.
[30] Lan P, Gambier F, Pizzi A, Zhou DG, Brosse N. Wood
adhesives from agricultural by-products: lignins and tannins
for the elaboration of particleboards. Cell Chem Technol
2012;46:457e62.
[31] Baran NY, Demir H€O, Kostekc¸i S, Sacak M. Poly-2-[(4-
methylbenzylidene)amino]phenol: investigation of thermal
degradation and antimicrobial properties. J Appl Polym Sci
2014;132:357e67.
[32] Saad H, Khoukh A, Ayed N, Charrier B, Bouhtoury CE.
Characterization of Tunisian Aleppo pine tannins for a
potential use in wood adhesive formulation. Ind Crop Prod
2014;61:517e25.
[33] Wang XB, Cheng H, Zhao Y, Huang HT. Study on the EGCG
from tea on the blood anticoagulation effect of mice. J Tea Sci
2011;31:532e6.
[34] Bi Q, Han B, Feng Y, Jiang Z, Yang Y, Liu W. Antithrombotic
effects of a newly purified fibrinolytic protease from Urechis
unicinctus. Thromb Res 2013;132:135e44.
[35] Furie B, Furie BC. Thrombus formation in vivo. J Clin Invest
2005;115:3355e62.
[36] Zhang QZ, Liu JT, Shi XL, Jing JL. Effect of non-heating leech
extract on coagulation system and platelet aggregation in the
animal model with blood hypercoagulable state. Chinese J
Exp Tradit Med Form 2006;12:47e9.
[37] Wei YX, Jing LI, Wang JC, Qi HT. Screening of different
fractions of phlorotannins from Sargassum thunbergii Kuntze
for anticoagulant activity. Chinese J Biochem Pharm
2007;28:227e9.
[38] Pa˚hlman LI, M€orgelin M, Kasetty G, Olin AI, Schmidtchen A,
Herwald H. Antimicrobial activity of fibrinogen and
fibrinogen-derived peptidesda novel link between
coagulation and innate immunity. Thromb Haemost
2013;109:930e9.
[39] Pop GA, Bisschops LL, Iliev B, Struijk PC, Hoeven JG,
Hoedemaekers C. On-line blood viscosity monitoring in vivo
with a central venous catheter, using electrical impedance
technique. Biosens Bioelectron 2013;41:595e601.
[40] da Silva E, Ficheux D, Coleman AW. Anti-thrombotic activity
of water-soluble calix[n]arenes. J Incl Phenom Macro
2005;52:201e6.operties and anticoagulant activity of polyphenols derived from
//dx.doi.org/10.1016/j.jfda.2016.08.011
